Vietnam Investment Reviev6h
Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma
Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from ...
Gilead Sciences Announces Fourth Quarter and Full Year 2024 Financial Results
Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024.
Hosted on MSN12h
There's a Chance Your Favorite Berries May Be Contaminated With Norovirus. The FDA Is Trying to Make Them Safer
Fact checked by Nick Blackmer The FDA has recently announced a new plan to improve the safety of imported berries.Fresh and ...
con-telegraph.ie15h
Increase in Hepatitis A cases in Mayo noted
The Department of Public Health HSE West and North West has been notified of an increase of Hepatitis A cases in Mayo and is ...
con-telegraph.ie15h
HSE issues Mayo Hepatitis A alert due to hike in infections
The Department of Public Health HSE West and North West has been notified of an increase of Hepatitis A cases County Mayo and ...
Gov17h
Protect Your Liver: DOH urges awareness and prevention to combat liver disease
By promoting awareness, encouraging preventive practices, and ensuring access to essential healthcare services, the DOH aims to reduce the burden of liver diseases and improve the overall well-being ...
NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...